Benzinga | Jul 8, 2021 07:02AM EDT

SVB Leerink Initiates Coverage On F-star Therapeutics with Outperform Rating, Announces Price Target of $39

SVB Leerink analyst Daina Graybosch initiates coverage on F-star Therapeutics (NASDAQ:FSTX) with a Outperform rating and announces Price Target of $39.